Fluorecare 6-in-1 (SARS-CoV-2, Грипп A/B, RSV, ADV, hMPV)

Fluorecare 6-in-1 (SARS-CoV-2, Flu A/B, RSV, ADV, hMPV)

Extended rapid test for differential diagnosis of viral respiratory infections

Fluorecare 6-in-1 allows simultaneous detection of six viruses in nasal swab samples:

• SARS-CoV-2 (COVID-19)

• Influenza A virus

• Influenza B virus

• Respiratory syncytial virus (RSV)

• Adenovirus (ADV)

• Human metapneumovirus (hMPV)

Clinical significance

Laboratory differential diagnosis of respiratory viral infections is critical as the symptoms of many diseases are similar, but therapeutic approaches are different.

• Adenovirus (ADV) can cause pharyngitis, conjunctivitis, pneumonia, gastroenteritis, and severe lower respiratory infections.

• Human metapneumovirus (hMPV) frequently causes bronchiolitis and pneumonia, particularly in children, elderly people, and immunocompromised patients.

Indications for use

• Patients with acute respiratory symptoms of unclear etiology

• Outbreaks of viral infections in hospitals, schools, nursing homes

• Complicated respiratory infections requiring differential diagnosis

• Rapid assessment of infectious status before antiviral therapy

Key features

• Method: Immunochromatography

• Sample type: Nasal swab

• Test format: Cassette

• Number of tests per pack: 25

• Time to result: 15-20 minutes

• Storage temperature: +2…+30°C

• Shelf life: Up to 24 months

• Certification: CE, ISO 13485

📌 Rapid pathogen detection helps personalize patient treatment, prevent unnecessary antibiotic use, and reduce the spread of viral infections.